Form 4: Zebra Technologies Executive Chair Anders Gustafsson Reports Stock Transactions
SEC Form 4
Anders Gustafsson, Executive Chair of Zebra Technologies, reports acquisition and disposal of Class A Common Stock on May 9, 2024.
Summary
- Anders Gustafsson, the Executive Chair of Zebra Technologies, reported transactions involving Class A Common Stock.
- On May 9, 2024, Gustafsson acquired 696 shares of Class A Common Stock at a price of $316.5 per share.
- On the same day, Gustafsson disposed of 12,066 shares of Class A Common Stock at a price of $316.5 per share.
- Following these transactions, Gustafsson beneficially owns 198,187 shares of Class A Common Stock directly.
- Gustafsson also holds stock appreciation rights (SARs) with varying exercise prices and expiration dates.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing reporting stock transactions, which is neutral in sentiment.
Industry Context
This Form 4 filing is a routine disclosure of stock transactions by a company insider, which is a common occurrence for publicly traded companies. It provides transparency into the trading activities of key personnel.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in beneficial ownership.
- The filing provides transparency to stakeholders regarding insider trading activities.
Key Dates
| Date | Description |
|---|---|
| 05/12/2017 | Vesting date for 10,564 stock appreciation rights (SARs) with an exercise price of $51.42. |
| 05/12/2018 | Vesting date for 10,564 stock appreciation rights (SARs) with an exercise price of $51.42. |
| 05/10/2019 | Vesting date for 6,303 stock appreciation rights (SARs) with an exercise price of $149.57. |
| 05/12/2019 | Vesting date for 10,564 stock appreciation rights (SARs) with an exercise price of $51.42. |
| 05/02/2020 | Vesting date for 5,844 stock appreciation rights (SARs) with an exercise price of $205.12. |
| 05/10/2020 | Vesting date for 6,303 stock appreciation rights (SARs) with an exercise price of $149.57. |
| 05/12/2020 | Vesting date for 10,564 stock appreciation rights (SARs) with an exercise price of $51.42. |
| 04/30/2021 | Vesting date for 5,033 stock appreciation rights (SARs) with an exercise price of $244.97. |
| 05/02/2021 | Vesting date for 5,845 stock appreciation rights (SARs) with an exercise price of $205.12. |
| 05/10/2021 | Vesting date for 6,304 stock appreciation rights (SARs) with an exercise price of $149.57. |
| 04/30/2022 | Vesting date for 5,033 stock appreciation rights (SARs) with an exercise price of $244.97. |
| 05/02/2022 | Vesting date for 5,845 stock appreciation rights (SARs) with an exercise price of $205.12. |
| 05/10/2022 | Vesting date for 6,304 stock appreciation rights (SARs) with an exercise price of $149.57. |
| 04/30/2023 | Vesting date for 5,034 stock appreciation rights (SARs) with an exercise price of $244.97. |
| 05/02/2023 | Vesting date for 5,845 stock appreciation rights (SARs) with an exercise price of $205.12. |
| 04/30/2024 | Vesting date for 5,034 stock appreciation rights (SARs) with an exercise price of $244.97. |
| 05/09/2024 | Date of Class A Common Stock acquisition and disposal transactions. |
| 05/13/2024 | Date of report filing. |
| 05/10/2025 | Expiration date for stock appreciation rights (SARs) with an exercise price of $149.57. |
| 05/12/2026 | Expiration date for stock appreciation rights (SARs) with an exercise price of $51.42. |
| 05/02/2026 | Expiration date for stock appreciation rights (SARs) with an exercise price of $205.12. |
| 04/30/2027 | Expiration date for stock appreciation rights (SARs) with an exercise price of $244.97. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.